跳至主要内容
临床试验/NL-OMON35218
NL-OMON35218尚未招募不适用

A double blind, randomized placebo-controlled cross-over study on the cardiovascular effects of Salvia miltiorrhiza extract (Danshen) in patients with hypertension and hyperlipidemia - Cardiovascular effects of Salvia miltiorrhiza extract (Danshen)

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Age: 40-70 (50% men / 50% women)
  • - postmenopausal, or
  • - use of contraceptive pill
  • * Hyperlipidemia
  • - elevated level of triglycerides: > 1.7 mmol/L
  • - elevated level of LDL-cholesterol: > 3.5 mmol/L
  • - reduced level of HDL-cholesterol: < 1.03 mmol/L
  • * Hypertension:
  • - systolic pressure > 90 mm Hg
  • - diastolic pressure > 140 mm Hg
  • * Signed informed consent

排除标准

  • * Alcohol or drug abuse
  • * History of cardiovascular disease (myocard infarct, angina pectoris, CVA, CI)
  • * Diabetes mellitus
  • * Pregnancy
  • * Concomitant (chronic) use of:
  • - ACE-inhibitors
  • - Anticoagulant drugs
  • - > 1 antihypertensive drug
  • - High-dose antihypertensive medication (above defined daily dose)
  • - (Antioxidant) vitamin supplements
  • * Clinically significant liver disease (3 times the upper normal limit of ALAT,ASAT,AF, *GT or LDH)
  • * Clinically significant anemia (male Hb < 6,9 mmol/L, female < 6,25 mmol/L)
  • * Abnormal creatinine clearance (adjusted for age of subject)
  • * Participation to any drug-investigation during the previous 90 days

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验